Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Nat Med ; 30(5): 1448-1460, 2024 May.
Artículo en Inglés | MEDLINE | ID: mdl-38760586

RESUMEN

In a previous study, heart xenografts from 10-gene-edited pigs transplanted into two human decedents did not show evidence of acute-onset cellular- or antibody-mediated rejection. Here, to better understand the detailed molecular landscape following xenotransplantation, we carried out bulk and single-cell transcriptomics, lipidomics, proteomics and metabolomics on blood samples obtained from the transplanted decedents every 6 h, as well as histological and transcriptomic tissue profiling. We observed substantial early immune responses in peripheral blood mononuclear cells and xenograft tissue obtained from decedent 1 (male), associated with downstream T cell and natural killer cell activity. Longitudinal analyses indicated the presence of ischemia reperfusion injury, exacerbated by inadequate immunosuppression of T cells, consistent with previous findings of perioperative cardiac xenograft dysfunction in pig-to-nonhuman primate studies. Moreover, at 42 h after transplantation, substantial alterations in cellular metabolism and liver-damage pathways occurred, correlating with profound organ-wide physiological dysfunction. By contrast, relatively minor changes in RNA, protein, lipid and metabolism profiles were observed in decedent 2 (female) as compared to decedent 1. Overall, these multi-omics analyses delineate distinct responses to cardiac xenotransplantation in the two human decedents and reveal new insights into early molecular and immune responses after xenotransplantation. These findings may aid in the development of targeted therapeutic approaches to limit ischemia reperfusion injury-related phenotypes and improve outcomes.


Asunto(s)
Trasplante de Corazón , Xenoinjertos , Trasplante Heterólogo , Humanos , Animales , Porcinos , Masculino , Femenino , Rechazo de Injerto/inmunología , Rechazo de Injerto/genética , Proteómica , Metabolómica , Leucocitos Mononucleares/metabolismo , Leucocitos Mononucleares/inmunología , Transcriptoma , Perfilación de la Expresión Génica , Linfocitos T/inmunología , Linfocitos T/metabolismo , Lipidómica , Daño por Reperfusión/inmunología , Daño por Reperfusión/genética , Daño por Reperfusión/metabolismo , Multiómica
2.
Nat Commun ; 15(1): 3361, 2024 Apr 18.
Artículo en Inglés | MEDLINE | ID: mdl-38637524

RESUMEN

Xenotransplantation represents a possible solution to the organ shortage crisis and is an imminent clinical reality with long-term xenograft survival in pig-to-nonhuman primate (NHP) heart and kidney large animal models, and short-term success in recent human decedent and clinical studies. However, concerns remain about safe clinical translation of these results, given the inconsistency in published survival as well as key differences between preclinical procurement and immunosuppression and clinical standards-of-care. Notably, no studies of solid organ pig-to-NHP transplantation have achieved xenograft survival longer than one month without CD40/CD154 costimulatory blockade, which is not currently an FDA-approved immunosuppression strategy. We now present consistent survival in consecutive cases of pig-to-NHP kidney xenotransplantation, including long-term survival after >3 hours of xenograft cold preservation time as well as long-term survival using FDA-approved immunosuppression. These data provide critical supporting evidence for the safety and feasibility of clinical kidney xenotransplantation. Moreover, long-term survival without CD40/CD154 costimulatory blockade may provide important insights for immunosuppression regimens to be considered for first-in-human clinical trials.


Asunto(s)
Supervivencia de Injerto , Riñón , Animales , Humanos , Porcinos , Trasplante Heterólogo/métodos , Xenoinjertos , Terapia de Inmunosupresión/métodos , Ligando de CD40 , Antígenos CD40 , Rechazo de Injerto
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA